PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 875 (102nd)

RU-486 Regulatory Fairness Act of 1991

referredUnited States· United States Congress· EN

Introduced

6 February 1991

Last action

19 February 1991 · Referred

Status

Referred to the Subcommittee on Health and the Environment.

Sponsors

Sen. Wyden, Ron [D-OR], Rep. Boxer, Barbara [D-CA-6], Rep. Molinari, Susan [R-NY-14], Rep. Owens, Major R. [D-NY-12], Rep. McDermott, Jim [D-WA-7], Rep. Beilenson, Anthony C. [D-CA-23], Rep. Kostmayer, Peter H. [D-PA-8], Rep. Waxman, Henry A. [D-CA-24], Rosa DeLauro, Rep. Lipinski, William O. [D-IL-5], Rep. Levine, Mel [D-CA-27], Rep. Green, S. William [R-NY-15], Rep. Martinez, Matthew G. [D-CA-30], Rep. Hughes, William J. [D-NJ-2], Rep. Mrazek, Robert J. [D-NY-3], Rep. Carr, Bob [D-MI-6], NITA LOWEY, Rep. Kopetski, Mike [D-OR-5], Rep. Campbell, Tom [R-CA-12], Rep. Andrews, Robert E. [D-NJ-1], Rep. Nagle, Dave R, [D-IA-3], Rep. Anderson, Glenn M. [D-CA-32], Rep. Towns, Edolphus [D-NY-11], Nancy Pelosi, Rep. Unsoeld, Jolene [D-WA-3], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Edwards, Don [D-CA-10], Rep. Berman, Howard L. [D-CA-26], Rep. Stark, Fortney Pete [D-CA-9], Rep. Foglietta, Thomas M. [D-PA-1], Rep. Morella, Constance A. [R-MD-8], Rep. Dellums, Ronald V. [D-CA-8], Rep. Yates, Sidney R. [D-IL-9], Rep. Skaggs, David E. [D-CO-2], ELIOT ENGEL, Rep. Feighan, Edward F. [D-OH-19], Rep. Fazio, Vic [D-CA-4], JOHN CONYERS, Rep. Miller, George [D-CA-7], Rep. Studds, Gerry E. [D-MA-12], Maxine Waters, Rep. Matsui, Robert T. [D-CA-3], PETER DEFAZIO, Rep. Frank, Barney [D-MA-4], Rep. Andrews, Thomas H. [D-ME-1], Rep. Jontz, Jim [D-IN-5], Rep. Panetta, Leon [D-CA-16], Rep. Johnson, Nancy L. [R-CT-6]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

RU-486 Regulatory Fairness Act of 1991 - Declares that a specified import alert issued by the Food and Drug Administration (FDA) with respect to the drug RU-486 shall not have any legal effect and shall be withdrawn by the FDA. (RU-486 has been used outside the United States to abort pregnancies.) Prohibits the FDA from taking any action to bar the import of that drug unless the FDA finds that it is being imported for an illegal use. Requires the FDA to give consideration in accordance with provisions relating to new drug approval when an application is submitted under such provisions for RU-486.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 6 February 1991

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 6 February 1991

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 6 February 1991

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 19 February 1991

    Referred

    Referred to the Subcommittee on Health and the Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

2 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 70 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.